Literature DB >> 30727753

Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis.

Brian T Steffen1, George Thanassoulis2, Daniel Duprez3, James H Stein4, Amy B Karger1, Mathew C Tattersall4, Joel D Kaufman5, Weihua Guan6, Michael Y Tsai1.   

Abstract

Objective- Lp(a) [lipoprotein(a)] is a well-described risk factor for atherosclerosis, but Lp(a)-associated risk may vary by race/ethnicity. We aimed to determine whether race/ethnicity modifies Lp(a)-related risk of carotid atherosclerotic plaque outcomes among black, white, Chinese, and Hispanic individuals. Approach and Results- Carotid plaque presence and score were assessed by ultrasonography at baseline (n=5155) and following a median 9.4 year period (n=3380) in MESA (Multi-Ethnic Study of Atherosclerosis) participants. Lp(a) concentrations were measured by immunoassay and examined as a continuous and categorical variable using clinically-based cutoffs, 30 and 50 mg/dL. Lp(a) was related to greater risk of prevalent carotid plaque at baseline in whites alone (all P<0.001): per log unit (relative risk, 1.05); Lp(a)≥30 mg/dL (relative risk, 1.16); and Lp(a)≥50 mg/dL (relative risk, 1.20). Lp(a) levels over 50 mg/dL were associated with a higher plaque score at baseline in whites (all P<0.001) and Hispanics ( P=0.04). In prospective analyses, whites with Lp(a) ≥50 mg/dL were found to have greater risk of plaque progression (relative risk, 1.12; P=0.03) and higher plaque scores (all P<0.001) over the 9.4-year follow-up. Race-based differences between whites and black participants were significant for cross-sectional associations and for carotid plaque score following the 9.4 year study period. Conclusions- Race was found to be a modifying variable in Lp(a)-related risk of carotid plaque, and Lp(a) levels may have greater influence on plaque burden in whites than in black individuals. Borderline results in Hispanics suggest that elevated Lp(a) may increase the risk of carotid plaque, but follow-up studies are needed.

Entities:  

Keywords:  atherosclerosis; diabetes mellitus; immunoassay; lipoprotein(a); ultrasonography

Mesh:

Substances:

Year:  2019        PMID: 30727753      PMCID: PMC6393189          DOI: 10.1161/ATVBAHA.118.312267

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  47 in total

1.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.

Authors:  S M Marcovina; J J Albers; E Wijsman; Z Zhang; N H Chapman; H Kennedy
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

2.  Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.

Authors:  N W Boonmark; X J Lou; Z J Yang; K Schwartz; J L Zhang; E M Rubin; R M Lawn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.

Authors:  Brian G Kral; Rita R Kalyani; Lisa R Yanek; Dhananjay Vaidya; Elliot K Fishman; Diane M Becker; Lewis C Becker
Journal:  Am J Cardiol       Date:  2016-07-05       Impact factor: 2.778

4.  Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.

Authors:  Simone L Verweij; Maurice W J de Ronde; Rutger Verbeek; S Matthijs Boekholdt; R Nils Planken; Erik S G Stroes; Sara-Joan Pinto-Sietsma
Journal:  J Clin Lipidol       Date:  2018-02-16       Impact factor: 4.766

5.  Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups.

Authors:  Brian T Steffen; Daniel Duprez; Alain G Bertoni; Weihua Guan; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

6.  Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Jing Cao; Brian T Steffen; Matthew Budoff; Wendy S Post; George Thanassoulis; Bryan Kestenbaum; Joseph P McConnell; Russell Warnick; Weihua Guan; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

7.  Quantification of apo[a] and apoB in human atherosclerotic lesions.

Authors:  J M Pepin; J A O'Neil; H F Hoff
Journal:  J Lipid Res       Date:  1991-02       Impact factor: 5.922

8.  Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.

Authors:  Taewoo Cho; Yoojin Jung; Marlys L Koschinsky
Journal:  J Biol Chem       Date:  2008-09-05       Impact factor: 5.157

9.  Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  P J Schreiner; G Heiss; H A Tyroler; J D Morrisett; C E Davis; R Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

10.  Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael Y Tsai; Craig Johnson; W H Linda Kao; A Richey Sharrett; Valerie L Arends; Richard Kronmal; Nancy Swords Jenny; David R Jacobs; Donna Arnett; Daniel O'Leary; Wendy Post
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

View more
  11 in total

1.  Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort.

Authors:  Eric J Brandt; Arya Mani; Erica S Spatz; Nihar R Desai; Khurram Nasir
Journal:  J Clin Lipidol       Date:  2020-07-03       Impact factor: 4.766

2.  Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.

Authors:  Kwok Leung Ong; Robyn L McClelland; Matthew A Allison; Mary Cushman; Parveen K Garg; Michael Y Tsai; Kerry-Anne Rye; Fatiha Tabet
Journal:  Metabolism       Date:  2021-01-07       Impact factor: 8.694

Review 3.  Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation.

Authors:  Gissette Reyes-Soffer; Marit Westerterp
Journal:  Pharmacol Res       Date:  2021-05-23       Impact factor: 10.334

4.  Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study.

Authors:  Chunyue Guo; Han Cao; Guangliang Shan; Wei Zhao; Han Zhang; Kaijun Niu; Ze Cui; Naijun Tang; Kuo Liu; Li Pan; Xiaoyan Han; Zhengfang Wang; Ge Meng; Jixin Sun; Anqi Shan; Yuxiang Yan; Huijing He; Zhiyuan Xu; Yajing Cao; Wenjuan Peng; Yanyan Sun; Yunyi Xie; Xiaohui Liu; Bingxiao Li; Fuyuan Wen; Ling Zhang
Journal:  Ann Transl Med       Date:  2021-01

5.  Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis.

Authors:  Xiaoyan Ren; Zhihui Zhang; Zhaoli Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-24       Impact factor: 5.555

6.  Association of lipoprotein(a) with aortic dissection.

Authors:  Yiheng Yang; Yuting Hong; Weihua Yang; Zhenzhong Zheng
Journal:  Clin Cardiol       Date:  2022-08-04       Impact factor: 3.287

7.  Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.

Authors:  Aniruddh P Patel; Minxian Wang (汪敏先); James P Pirruccello; Patrick T Ellinor; Kenney Ng; Sekar Kathiresan; Amit V Khera
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

8.  Loci identified by a genome-wide association study of carotid artery stenosis in the eMERGE network.

Authors:  Melody R Palmer; Daniel S Kim; David R Crosslin; Ian B Stanaway; Elisabeth A Rosenthal; David S Carrell; David J Cronkite; Adam Gordon; Xiaomeng Du; Yatong K Li; Marc S Williams; Chunhua Weng; Qiping Feng; Rongling Li; Sarah A Pendergrass; Hakon Hakonarson; David Fasel; Sunghwan Sohn; Patrick Sleiman; Samuel K Handelman; Elizabeth Speliotes; Iftikhar J Kullo; Eric B Larson; Gail P Jarvik
Journal:  Genet Epidemiol       Date:  2020-09-22       Impact factor: 2.135

9.  Plasma lipid profiles in early adulthood are associated with epigenetic aging in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Tao Gao; John T Wilkins; Yinan Zheng; Brian T Joyce; David R Jacobs; Pamela J Schreiner; Steve Horvath; Philip Greenland; Donald Lloyd-Jones; Lifang Hou
Journal:  Clin Epigenetics       Date:  2022-01-31       Impact factor: 6.551

Review 10.  Diabetes and carotid artery disease: a narrative review.

Authors:  Niki Katsiki; Dimitri P Mikhailidis
Journal:  Ann Transl Med       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.